Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| astrocyte | 10 studies | 36% ± 17% | |
| adipocyte | 8 studies | 35% ± 8% | |
| epithelial cell | 4 studies | 25% ± 9% | |
| hepatocyte | 4 studies | 47% ± 28% | |
| oligodendrocyte | 4 studies | 22% ± 5% | |
| mucus secreting cell | 3 studies | 23% ± 4% | |
| GABAergic neuron | 3 studies | 37% ± 3% | |
| glutamatergic neuron | 3 studies | 41% ± 6% | |
| abnormal cell | 3 studies | 27% ± 11% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 34% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 6442.88 | 2637 / 2642 | 100% | 98.87 | 704 / 705 |
| liver | 100% | 11801.04 | 226 / 226 | 90% | 76.69 | 364 / 406 |
| prostate | 88% | 5425.04 | 215 / 245 | 100% | 87.72 | 501 / 502 |
| pancreas | 100% | 12475.75 | 328 / 328 | 79% | 17.24 | 141 / 178 |
| stomach | 86% | 9877.00 | 309 / 359 | 86% | 32.06 | 247 / 286 |
| breast | 84% | 3641.66 | 385 / 459 | 82% | 25.40 | 922 / 1118 |
| adrenal gland | 95% | 2082.61 | 244 / 258 | 61% | 12.28 | 141 / 230 |
| kidney | 90% | 3241.97 | 80 / 89 | 47% | 9.35 | 422 / 901 |
| skin | 95% | 5499.20 | 1719 / 1809 | 40% | 6.97 | 189 / 472 |
| esophagus | 45% | 4481.44 | 651 / 1445 | 85% | 26.44 | 155 / 183 |
| intestine | 35% | 616.48 | 341 / 966 | 93% | 39.13 | 492 / 527 |
| ureter | 0% | 0 | 0 / 0 | 100% | 18.22 | 1 / 1 |
| ovary | 6% | 89.59 | 11 / 180 | 93% | 27.99 | 398 / 430 |
| uterus | 8% | 145.24 | 13 / 170 | 89% | 27.58 | 410 / 459 |
| muscle | 95% | 7719.14 | 759 / 803 | 0% | 0 | 0 / 0 |
| bladder | 5% | 61.76 | 1 / 21 | 90% | 30.53 | 452 / 504 |
| lung | 8% | 109.32 | 46 / 578 | 83% | 28.85 | 960 / 1155 |
| adipose | 84% | 4423.85 | 1015 / 1204 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 82% | 24.70 | 37 / 45 |
| thymus | 33% | 505.60 | 214 / 653 | 37% | 8.87 | 223 / 605 |
| lymph node | 0% | 0 | 0 / 0 | 66% | 14.50 | 19 / 29 |
| heart | 24% | 394.19 | 208 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 13% | 238.62 | 120 / 929 | 0% | 0 | 0 / 0 |
| blood vessel | 10% | 236.17 | 130 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 7% | 98.32 | 17 / 241 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 3% | 0.28 | 2 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0042851 | Biological process | L-alanine metabolic process |
| GO_0042853 | Biological process | L-alanine catabolic process |
| GO_0006103 | Biological process | 2-oxoglutarate metabolic process |
| GO_0009058 | Biological process | biosynthetic process |
| GO_0005759 | Cellular component | mitochondrial matrix |
| GO_0004021 | Molecular function | L-alanine:2-oxoglutarate aminotransferase activity |
| GO_0030170 | Molecular function | pyridoxal phosphate binding |
| Gene name | GPT2 |
| Protein name | Alanine aminotransferase 2 (ALT2) (EC 2.6.1.2) (Glutamate pyruvate transaminase 2) (GPT 2) (Glutamic--alanine transaminase 2) (Glutamic--pyruvic transaminase 2) alanine transaminase (EC 2.6.1.2) |
| Synonyms | ALT2 AAT2 |
| Description | FUNCTION: Catalyzes the reversible transamination between alanine and 2-oxoglutarate to form pyruvate and glutamate. . |
| Accessions | ENST00000562132.5 H3BU54 ENST00000340124.9 [Q8TD30-1] Q8TD30 ENST00000440783.2 [Q8TD30-2] |
